Drug provision for ischemic heart disease and arterial hypertension in the Republic of Tajikistan

Introduction. The increase in the incidence of coronary heart disease (CHD) and arterial hypertension (AH) in the Republic of Tajikistan, as well as the lack of social programs for drug provision, highlight the need to study the views of doctors regarding the prescription of drugs. Objective. To study the preferences and opinions of physicians regarding drug provision for coronary heart disease and arterial hypertension in the Republic of Tajikistan to identify ways to optimize and improve pharmaceutical care for these patients. Material and methods. The source for the research work were questionnaires of doctors of the Republican Clinical Center of Cardiology of the Republic of Tajikistan of all departments, the department of cardiorheumatology of the City Clinical Hospital No. 2 named after K. Tadjiev in Dushanbe, the National Diagnostic Center of the Republic of Tajikistan and City Health Centers No.1, 8, 10, 14, Dushanbe. The work uses methods of content analysis, systematization, generalization, descriptive statistics using the program MS Office Excel 2017". Results. 64% of physicians prefer fixed combinations or their combination with monotherapy. In 69% of cases, the choice of drug is influenced by the patient's ability to pay. Physicians generally follow clinical protocols, but only 52% systematically comply with them. An assessment of the availability of the latest drugs showed that almost half of physicians have only partial access to them. Most physicians have a positive attitude towards involving pharmacy workers in a multidisciplinary team of healthcare professionals in providing services to patients with coronary heart disease and hypertension. Conclusion. Fixed combinations are considered more effective, especially by younger and middle-aged cardiologists. Doctors choose drugs mainly without reference to the manufacturer, focusing on effectiveness. The patient's solvency is an important criterion when prescribing therapy. The physician respondents acknowledge the importance of interprofessional interaction with pharmacists, in particular in terms of polypharmacy, consultation and coordination of actions. The obtained results can be used to improve pharmaceutical care and expand the functionality of pharmacists within the team model of care